• You are here:
  • Grants
  • Research

The 2018 research grant applications cycle is closed.

The IUGA offers both Basic Science and Clinical Research Grants to fund original research by an IUGA member or trainee. The research grants are designed to fund development of the proposed research project including all materials and testing, statistical analyses, and services required to complete the research.

The grant cycle opens in the spring and typically closes prior to the Annual Meeting. Grants are awarded based on the Research and Development Committee’s review of application materials.

Awards

Two grants will be awarded:

  • USD 10,000 for a clinical patient-oriented research project
  • USD 10,000 for a laboratory-based/basic science research project

The initial USD 5,000 payment will be made upon award of the grant, and the remaining USD 5,000 will be paid upon receipt and review of the 6-month Interim Report. Ethical approval must be received, if applicable, by the IUGA Executive Office before any funds will be released. Grants will only be paid to an institution and not to an individual. All submitted applications will be reviewed, scored, and commented upon by members of the IUGA Research and Development Committee. Applicants will be notified of the outcome via email. Award recipients will be announced to the membership via email and recipient names will be included on the IUGA website.

Eligibility

  • Any IUGA member in good standing is eligible to apply for the grant program.
  • Applicant must remain at the same institution for the entire funding period.

Submission Instructions

A complete grant application must be submitted via email to the IUGA Executive Office via email (This email address is being protected from spambots. You need JavaScript enabled to view it.) by the published deadline. All items listed below must be submitted as a single PDF with documents compiled in the order listed below. Only complete applications that include all required materials and explicitly follow these instructions will be forwarded to the Research and Development Committee for review. An IUGA Executive Office staff member will review each application for completeness before forwarding it to the Research and Development Committee for review and has the authority to disqualify an application if all required information, signatures, related documents, and/or page or word limit requirements are not followed.

Required Application Documents

  • Title Page (download form here)
  • PI Agreement (download form here)
  • Structured Abstract (limit 200 words)
  • Background Review
    • Describe the sponsoring institution
    • List previous research activities and accomplishments, especially as they relate to the proposed research project or your ability to complete the proposed research project. If including a CV, it must be brief and limited to 2 pages with only relevant information included.
    • Describe the goals and objectives of previous research as it relates to the proposed research project, as this provides a context for the work you plan to undertake.
    • Describe the service areas and populations served. Include a description of laboratory facilities, if applicable.
  • Research Protocol
    • Specific aims
    • Background/significance
    • Methodology
    • Ethics and Patient Consent (if applicable)
    • Ethics and Animal Studies (if applicable)
    • References (limit to 20)
  • Budget
    • Please indicate how the funds will be allocated in detail, in US dollars.
    • If the study is being funded by another source, this must be disclosed in the budget section, as well as on the Title Page.
    • Salaries for the Principle Investigator(s) and any co-investigator(s) are not supported.
    • Funding may include statistical analyses, tech support (i.e. sonographer), laboratory studies, diagnostic studies (i.e. post-treatment urodynamics), mailing and postage for questionnaires or other related material, and patient vouchers for transportation, meals, etc.
    • Funding may not include travel, computer, meeting fees and related expenses, equipment, manuscript preparation costs, indirect costs such as university overhead or IRB fees.
  • Evaluation Criteria and Progress
    • Describe what measures will be used to evaluate the progress of the research study.
    • Describe what records and information will be maintained to allow measurement of progress.
  • IRB Approval (if applicable)
    • Provide a copy of the IRB approval letter. If IRB approval is pending at the time of application submission, indicate the status of the IRB approval and an approximate date of approval. If approved, please include the IRB approval number. If exempt, please explain.
  • Appendices (if applicable)
    • Include any data collection forms, questionnaires, or other study-related materials.
  • Supporting Documentation
    • Provide at least two (2) letters of Support from the department/institution head and collaborators, such as those individuals supplying patient referrals.

Completed applications must be submitted via email to the IUGA office (This email address is being protected from spambots. You need JavaScript enabled to view it.) prior to the published deadline. Omission of any materials will disqualify your application. Grant applications must contain all required materials listed below, and must be submitted in one PDF document with items in the order listed below.

Questions should be directed to the IUGA Executive Office at This email address is being protected from spambots. You need JavaScript enabled to view it..

Post-Award Requirements

Interim Report

Grant recipients are required to submit a 6-month interim report (from the date of the first grant payment) reporting the progress of the research study to date. The Interim Report Form is available here. Interim Reports must be submitted electronically to the IUGA Executive Office (This email address is being protected from spambots. You need JavaScript enabled to view it.). All interim reports will be reviewed by the Research and Development Committee Chair and Grant Chair. More information may be requested prior to releasing the final grant payment.

Final Report

Grant recipients are required to submit a final report stating the results of the research study and an itemized budget showing how the funds were used, including providing receipts of paid items, where applicable. The final report is due to the IUGA Executive Office (This email address is being protected from spambots. You need JavaScript enabled to view it.) one month following the completion of the research study award period (7 months following the Interim Report). The Final Report Form is available here.

Presentation & Publication

Grant recipients are required to submit an abstract of their completed research study for presentation at the following IUGA Annual Meeting, and to submit a completed manuscript for publication to the International Urogynecology Journal.

Past IUGA Research Grant Recipients

2017

  • Basic Science: John Occhino & Marina Walther-Antonio, Evaluation of the Vaginal and Rectal Microbiome in Patients with Rectovaginal Fistula
  • Clinical: Catherine Hudson & Pamela Escobar Smith, A Pilot Randomized Controlled Trial of Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function

2016

  • Basic Science: Joseph Kowalski, A Randomized Controlled Trial of Permanent vs Absorbable Suture for Uterosacral Ligament Suspension
  • Clinical: Jonathan Duckett, Pilot Study to Address: Does the Presence of Lactobacillus in the Adult Female Bladder Protect Against OAB?

2015

  • IUGA ASTORA Women’s Health Clinical Research Grant: Rajeev Ramanah, Evaluating the Biomechanical Efficacy of Transvaginal Mesh Anterior and Apical Prolapse Repair Using Finite Element Modeling in Living Women
  • IUGA Cogentix Medical Clinical Research Grant: Cheryl Iglesia, Treatment of Refractory Overactive Bladder with Onabotulinumtoxin A vs PTNS: TROOP Trial

2014

  • Basic Science: Heinz Koelbl, Proteomic Pattern in Female Urinary Incontinence
  • Clinical: Shannon Lamb, Percutaneous Tibial Nerve Stimulation vs Transcutaneous Electrical Nerve Stimulation for Overactive Bladder: A Randomized Trial

2013

  • Basic Science: Gamal Ghoneim, Voiding Dysfunction and GABA Modulation in a Mouse Model of Cyclophosphamide-included Cystitis
  • Basic Science: Jennifer Rohn, Quiescent Intracellular Bacteria as Long-term Reservoirs in Recurrent Urinary Tract Infection (UTI) and Lower Urinary Tract Symptoms (LUTS) in Women
  • Clinical: Uduak Andy, Clinical and Biochemical Evidence of Neurogenic Inflammation in Women with Urinary Urgency
  • Clinical: Jane Manning, Prospective Randomized Double Blind Study into the Effectiveness of Intravaginal Lyrica® Cream for Chronic Vaginal Pain

2012

  • Basic Science: Michel Cosson, Biomechanical Modeling of the Pelvic Lesions Induced in Obstetrics Impact on Pelvic Floor Static
  • Clinical: M.M.E. Lakeman, Observational Study to Evaluate the Effects of Prolapse Surgery Using Synthetic Mesh on Vaginal Innervation, Genital Response and the Influence of These Changes on Sexual Well-being
  • Least-developed Countries: Barry O’Reilly, The Role of Cytokines in Overactive Bladder

2011

  • Basic Science: Sunil Balgobin, Repeat Injury to the External Anal Sphincter: Contractile Properties and Morphologic Changes Over Time
  • Clinical: Rufus Cartwright, Genome Wide Association Study of Urinary Incontinence in Women

2010

  • J Deprest, D Rizk, D De Ridder, HA Amer, E Mazza, Experimental Evaulation of the Effect of Age + Hormonal Status on Surgical Repair of Fascial Defects
  • C Walsh, K Moore, Y Cheng, Low Count Bacteruria and its Relationship to ATP Release in Refractory Detrusor Overactivity

2009

  • H Harvie, J Shea, L Arya, JS Schwartz, Health-related Quality of Life: Utility Preference for Pelvic Organ Prolapse
  • D Tincello, R Elliot, AH Taylor, J Willets, C Maynce, The Role and Significance of the Sweet Taste Receptor Isoform T1R3 in the Rodent and Human Bladder

2008

  • M Ho, N Bhatia, N Gonzalez-Cadavid, M Ferrini, I Kovanecz, Adipose-derived Stem Cell Therapy for Defective Pelvic Support and Stress Urinary Incontinence
  • J Malone-Lee, R Khasriya, R Lunawat, A Clinical Exploration of the Pathophysiology of an Inflammatory Response Associated with the Overactive Bladder
Ideas or Feedback?